Callan Family Office LLC Buys Shares of 17,350 Aflac Incorporated (NYSE:AFL)

Callan Family Office LLC bought a new stake in shares of Aflac Incorporated (NYSE:AFL) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 17,350 shares of the financial services provider’s stock, valued at approximately $1,795,000.

A number of other hedge funds have also added to or reduced their stakes in the stock. Private Trust Co. NA raised its stake in Aflac by 1.3% during the 4th quarter. Private Trust Co. NA now owns 7,643 shares of the financial services provider’s stock valued at $791,000 after buying an additional 99 shares during the last quarter. Phillips Wealth Planners LLC raised its stake in Aflac by 1.5% during the 4th quarter. Phillips Wealth Planners LLC now owns 6,553 shares of the financial services provider’s stock valued at $662,000 after buying an additional 100 shares during the last quarter. Raleigh Capital Management Inc. increased its stake in shares of Aflac by 23.2% in the 4th quarter. Raleigh Capital Management Inc. now owns 531 shares of the financial services provider’s stock worth $55,000 after purchasing an additional 100 shares in the last quarter. TKG Advisors LLC increased its stake in shares of Aflac by 0.5% in the 4th quarter. TKG Advisors LLC now owns 21,255 shares of the financial services provider’s stock worth $2,230,000 after purchasing an additional 103 shares in the last quarter. Finally, Covestor Ltd increased its stake in shares of Aflac by 41.8% in the 3rd quarter. Covestor Ltd now owns 363 shares of the financial services provider’s stock worth $41,000 after purchasing an additional 107 shares in the last quarter. 67.44% of the stock is currently owned by hedge funds and other institutional investors.

Aflac Stock Up 0.5 %

AFL opened at $108.48 on Friday. The firm has a 50-day simple moving average of $105.08 and a two-hundred day simple moving average of $107.70. Aflac Incorporated has a 52 week low of $79.31 and a 52 week high of $115.50. The company has a market capitalization of $59.29 billion, a PE ratio of 11.30, a price-to-earnings-growth ratio of 3.24 and a beta of 0.93. The company has a quick ratio of 0.08, a current ratio of 0.10 and a debt-to-equity ratio of 0.29.

Aflac (NYSE:AFL) last released its quarterly earnings data on Wednesday, February 5th. The financial services provider reported $1.56 EPS for the quarter, missing the consensus estimate of $1.63 by ($0.07). Aflac had a net margin of 28.76% and a return on equity of 16.20%. Analysts forecast that Aflac Incorporated will post 6.88 earnings per share for the current fiscal year.

Insider Buying and Selling at Aflac

In related news, EVP Audrey B. Tillman sold 24,744 shares of the stock in a transaction dated Friday, December 27th. The shares were sold at an average price of $103.40, for a total value of $2,558,529.60. Following the completion of the transaction, the executive vice president now owns 222,618 shares of the company’s stock, valued at approximately $23,018,701.20. This trade represents a 10.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 0.90% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms have recently commented on AFL. Keefe, Bruyette & Woods reduced their price objective on Aflac from $107.00 to $104.00 and set a “market perform” rating for the company in a research note on Wednesday, February 12th. Wells Fargo & Company reduced their price objective on Aflac from $104.00 to $102.00 and set an “equal weight” rating for the company in a research note on Wednesday, February 19th. Barclays reduced their price objective on Aflac from $98.00 to $95.00 and set an “underweight” rating for the company in a research note on Friday, February 7th. Evercore ISI reduced their price objective on Aflac from $104.00 to $102.00 and set an “underperform” rating for the company in a research note on Wednesday, December 4th. Finally, Piper Sandler reduced their price objective on Aflac from $122.00 to $118.00 and set an “overweight” rating for the company in a research note on Friday, February 7th. Two investment analysts have rated the stock with a sell rating, eleven have issued a hold rating and two have issued a buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $103.36.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.